We are currently upgrading our print fulfillment systems. Print book orders placed between Sept 22 and Oct 9 will be delayed. Delivery of these orders will start on Oct 10, with purchases being fulfilled in the order received. Buy the Print and get eBook immediately for FREE. Use Code BOGO. Or save up to 40% on all orders with code: DELTA. Exclusions apply. Click here for terms and conditions.
»
Advances in DNA Sequence-specific Agents, Volume 1
 
 

Advances in DNA Sequence-specific Agents, Volume 1, 1st Edition

 
Advances in DNA Sequence-specific Agents, Volume 1, 1st Edition,L.H. Hurley,ISBN9781559381659
 
 
 

L Hurley   

Elsevier Science

9781559381659

Print Book

Hardcover

In Stock

Estimated Delivery Time
USD 72.95
 
 

Description

This volume is aimed in general at scientists who have an interest in deciphering the molecular mechanisms for sequence recognition of DNA. The methods have general applicability to small molecules as well as oligomers and proteins, while the examples provide general principles involved in sequence recognition.

Readership

For scientists and researchers in the field of DNA sequenencing.

L.H. Hurley

Affiliations and Expertise

The Drug Dynamics Institute College of Pharmacy, The University of Texas at Austin, TX, USA

Advances in DNA Sequence-specific Agents, Volume 1, 1st Edition

List of Contributors. Introduction to the series: an editor's foreword (A. Padwa). Preface (L.H. Hurley).
Part I: Methods used to evaluate sequence specificity of DNA reactive compounds.
Application of equilibrium binding methods to elucidate the sequence specificity of antibiotic binding to DNA (J.B. Chaires). Quantitative aspects of DNASE 1+ footprinting (J.Goodisman, J.C. Dabrowiak). Use of circular dichroism to probe DNA structure and drug binding to DNA (C. Zimmer, G. Luck). NMR analysis of reversible nucleic acid-small molecule complexes (W.D. Wilson et al.). Use of enzymatic and chemical probes to determine the effect of drug binding on local DNA structure (K.R. Fox).
Part II: Sequence specificity of drugs that interact with DNA in the minor groove.
The DNA sequence selectivity of CC-1065 (M.A. Warpehoski). Mitomycin C: DNA sequence specificity of a natural DNA cross-linking agent (M. Tomasz). Sequence specificity of the pyrrolo(1,4)benzodiazepines (J.A. Mountzouris, L.H. Hurley). Calicheamicin/esperamicin (G. Ellestad et al.). DNA sequence controls mechanism of oxidative deoxyribose damage by neocarzinostatin (I.H. Goldberg). Index.
 
 
Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy
FAQ